← Back to Search

Optical and infrared imaging for Breast Cancer

N/A
Waitlist Available
Led By Michele Svatos, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- All female patients referred for adjuvant radiotherapy following breast conserving surgery/mastectomy.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week five of radiation treatment
Awards & highlights

Study Summary

This trial is testing whether a computer model can accurately predict when a cancer patient's skin will become painful during radiation treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week eight, follow-up after treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and week eight, follow-up after treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Establish the correlation between optical and IR skin imaging and skin toxicity
Secondary outcome measures
Skin
Diagnostic Imaging

Trial Design

1Treatment groups
Experimental Treatment
Group I: Receiving optical and infrared imagingExperimental Treatment1 Intervention
This is the only arm of the study. All patients will have optical and infrared images acquired of skin on the treated and contralateral sides.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
255 Previous Clinical Trials
83,489 Total Patients Enrolled
4 Trials studying Breast Cancer
236 Patients Enrolled for Breast Cancer
Michele Svatos, PhDPrincipal InvestigatorDalhousie University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Journal of Clinical OncologyJournal
A Multicenter Randomized Trial of Breast Intensity-modulated Radiation Therapy to Reduce Acute Radiation Dermatitis
Pignol, Jean-Philippe, Ivo Olivotto, Eileen Rakovitch, Sandra Gardner, Katharina Sixel, Wayne Beckham, Thi Trinh Thuc Vu, Pauline Truong, Ida Ackerman, and Lawrence Paszat. 2008. “A Multicenter Randomized Trial of Breast Intensity-modulated Radiation Therapy to Reduce Acute Radiation Dermatitis”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2007.15.2488.
Radiotherapy and OncologyJournal
Relationship Between Early and Late Normal-tissue Injury After Postmastectomy Radiotherapy
Bentzen, Søren M., and Marie Overgaard. 1991. “Relationship Between Early and Late Normal-tissue Injury After Postmastectomy Radiotherapy”. Radiotherapy and Oncology. Elsevier BV. doi:10.1016/0167-8140(91)90092-u.
Breast CancerJournal
Results of a Questionnaire Survey for Symptom of Late Complications Caused by Radiotherapy in Breast Conserving Therapy
Ishiyama, Hiromichi, Keiji Niino, Takaaki Hosoya, and Kazushige Hayakawa. 2006. “Results of a Questionnaire Survey for Symptom of Late Complications Caused by Radiotherapy in Breast Conserving Therapy”. Breast Cancer. Springer Science and Business Media LLC. doi:10.2325/jbcs.13.197.
International Journal of Radiation Oncology*Biology*PhysicsJournal
Pathophysiology of Irradiated Skin and Breast
Archambeau, John O., Richard Pezner, and Todd Wasserman. 1995. “Pathophysiology of Irradiated Skin and Breast”. International Journal of Radiation Oncology*biology*physics. Elsevier BV. doi:10.1016/0360-3016(94)00423-i.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top